Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer
about
MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the BrainToxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapyBiocompatible nanopolymers: the next generation of breast cancer treatment?Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid)The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Receptor-Mediated Drug Delivery Systems Targeting to GliomaStrategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide.Oligonucleotide-based theranostic nanoparticles in cancer therapy.Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive PromoterCurcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.Covalent nano delivery systems for selective imaging and treatment of brain tumors.Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers.Quantitative analysis of PMLA nanoconjugate components after backbone cleavageSimultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
P2860
Q29248327-308231DC-3B68-4220-BA5D-71315DCE60EDQ33705431-9C999911-61E0-4393-8EB3-C56CCF534420Q33802940-DB91323C-51C4-41C9-844B-50D42F0C9345Q33864065-3F46985B-2D31-4DD7-AC55-A3BDF11E167AQ36321843-7FBDBCF2-71A9-4CB3-9513-4AE255A8CA61Q37304764-9E1CD191-C2E6-4739-B7EF-51AF7B7239FFQ37422972-C5977430-3851-40EF-AFFD-E55CB958AC5FQ37636271-E1F635AB-38DD-4A45-ADB3-B1D2FB21FFF1Q38494470-01D4074B-29EA-4E95-AF96-6CFBADDF6413Q38777346-E36B0E6D-83FE-4184-B22E-0479C1823F80Q38814327-255BCDC9-7A2E-46E4-AFD3-D2B28D845666Q38834565-D3F9EEF9-E19A-4C82-8D3D-0D665CDDC347Q39047248-1C430C44-6C47-4BA2-96DD-8B86DF4F2E12Q39367664-1C77AC75-1F41-4000-850D-2E80F5F10B3DQ39537001-DB6266A7-2B7E-452D-95AF-5DAC8BAEAB30Q40458529-1B7F4B4C-122B-47B0-86E9-008CB7E3173CQ45997277-FF0E97A1-1D9A-4BA5-B8A9-ED8CF36BF1DD
P2860
Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Nanobiopolymer for direct targ ...... triple negative breast cancer
@ast
Nanobiopolymer for direct targ ...... triple negative breast cancer
@en
Nanobiopolymer for direct targ ...... triple negative breast cancer
@nl
type
label
Nanobiopolymer for direct targ ...... triple negative breast cancer
@ast
Nanobiopolymer for direct targ ...... triple negative breast cancer
@en
Nanobiopolymer for direct targ ...... triple negative breast cancer
@nl
prefLabel
Nanobiopolymer for direct targ ...... triple negative breast cancer
@ast
Nanobiopolymer for direct targ ...... triple negative breast cancer
@en
Nanobiopolymer for direct targ ...... triple negative breast cancer
@nl
P2093
P2860
P1433
P1476
Nanobiopolymer for direct targ ...... triple negative breast cancer
@en
P2093
Adam Elramsisy
Andres Espinoza
Bindu Konda
Dmitriy Mongayt
Eggehard Holler
H Westley Phillips
Janet L Markman
Jose Portilla-Arias
Julia Y Ljubimova
P2860
P304
P356
10.1371/JOURNAL.PONE.0031070
P407
P577
2012-01-01T00:00:00Z